Ngā hua rapu kaituhi :: APM

1

Immunotherapeutic Targeting of GPC3 in Pediatric Solid Embryonal Tumors mā Michael V. Ortiz, Stephen S. Roberts, Julia Glade Bender, Neerav Shukla, Leonard H. Wexler

I whakaputaina 2019

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Revisão

Tiaki ki tētahi rārangi

I tiakina i:
2

Coactivation of Receptor Tyrosine Kinases in Malignant Mesothelioma as a Rationale for Combination Targeted Therapy mā Marie Brevet, Shigeki Shimizu, Matthew J. Bott, Neerav Shukla, Qin Zhou, Adam B. Olshen, Valerie W. Rusch, Marc Ladanyi

I whakaputaina 2011

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
3

Oncogene Mutation Profiling of Pediatric Solid Tumors Reveals Significant Subsets of Embryonal Rhabdomyosarcoma and Neuroblastoma with Mutated Genes in Growth Signaling Pathways mā Neerav Shukla, Nabahet Ameur, İsmail Yılmaz, Khédoudja Nafa, Chyau-Yueh Lau, Angela Marchetti, Laetitia Borsu, Frederic G. Barr, Marc Ladanyi

I whakaputaina 2011

Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
4

TFE3 Fusions Activate MET Signaling by Transcriptional Up-regulation, Defining Another Class of Tumors as Candidates for Therapeutic MET Inhibition mā Masumi Tsuda, Ian J. Davis, Pedram Argani, Neerav Shukla, Gaël McGill, Makoto Nagai, Tsuyoshi Saito, Marick Laé, David E. Fisher, Marc Ladanyi

I whakaputaina 2007

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
5

Integrating Genomics Into Clinical Pediatric Oncology Using the Molecular Tumor Board at the Memorial Sloan Kettering Cancer Center mā Michael V. Ortiz, Rachel Kobos, Michael F. Walsh, Emily K. Slotkin, Stephen S. Roberts, Michael F. Berger, Meera Hameed, David B. Solit, Marc Ladanyi, Neerav Shukla, Alex Kentsis

I whakaputaina 2016

Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
6

$Impact of Bridging Chemotherapy on Clinical Outcomes of CD19-Specific CAR T Cell Therapy in Children/Young Adults with Relapsed/Refractory B Cell Acute Lymphoblastic Leukemia$

Impact of Bridging Chemotherapy on Clinical Outcomes of CD19-Specific CAR T Cell Therapy in Children/Young Adults with Relapsed/Refractory B Cell Acute Lymphoblastic Leukemia mā Sanam Shahid, Kavitha Ramaswamy, Jessica Flynn, Audrey Mauguen, Karlo Perica, Jae H. Park, Christopher J. Forlenza, Neerav Shukla, Peter G. Steinherz, Steven Margossian, Jaap Jan Boelens, Nancy A. Kernan, Kevin J. Curran

I whakaputaina 2021

Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
7

Mutational Inactivation of <i>STAG2</i> Causes Aneuploidy in Human Cancer mā David A. Solomon, Taeyeon Kim, Laura A. Díaz-Martínez, Joshlean Fair, Abdel Elkahloun, Brent T. Harris, Jeffrey A. Toretsky, Steven A. Rosenberg, Neerav Shukla, Marc Ladanyi, Yardena Samuels, C. David James, Hongtao Yu, Jung-Sik Kim, Todd Waldman

I whakaputaina 2011

Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
8

DNA Methylation–Based Classifier for Accurate Molecular Diagnosis of Bone Sarcomas mā Synphen Wu, Benjamin T. Cooper, Fang Bu, Christopher Bowman, J. Keith Killian, Jonathan Serrano, Shiyang Wang, Twana M. Jackson, Daniel Gorovets, Neerav Shukla, Paul A. Meyers, David J. Pisapia, Richard Görlick, Marc Ladanyi, Kristen Thomas, Matija Snuderl, Matthias A. Karajannis

I whakaputaina 2017

Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
9

Clinical Genomic Sequencing of Pediatric and Adult Osteosarcoma Reveals Distinct Molecular Subsets with Potentially Targetable Alterations mā Yoshiyuki Suehara, Deepu Alex, Anita S. Bowman, Sumit Middha, Ahmet Zehir, Debyani Chakravarty, Lu Wang, George Jour, Khédoudja Nafa, Takuo Hayashi, Achim A. Jungbluth, Denise Frosina, Emily K. Slotkin, Neerav Shukla, Paul A. Meyers, John H. Healey, Meera Hameed, Marc Ladanyi

I whakaputaina 2019

Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
10

Plasma DNA-Based Molecular Diagnosis, Prognostication, and Monitoring of Patients With <i>EWSR1</i> Fusion-Positive Sarcomas mā Neerav Shukla, Juber Patel, Heather Magnan, Ahmet Zehir, Daoqi You, Jiabin Tang, Fanli Meng, Aliaksandra Samoila, Emily K. Slotkin, Srikanth R. Ambati, Alexander J. Chou, Leonard H. Wexler, Paul A. Meyers, Ellinor I.B. Peerschke, Agnès Viale, Michael F. Berger, Marc Ladanyi

I whakaputaina 2017

Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
11

Cell‐free DNA profiling in retinoblastoma patients with advanced intraocular disease: An MSKCC experience mā Prachi Kothari, Francesco Marass, Julie L. Yang, Caitlin M. Stewart, Dennis Stephens, Juber Patel, Maysun Hasan, Xiaohong Jing, Fanli Meng, Jeanette Enriquez, Kety Huberman, Agnès Viale, Jasmine H. Francis, Michael F. Berger, Neerav Shukla, David H. Abramson, Ira J. Dunkel, Dana W.Y. Tsui

I whakaputaina 2020

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
12

A recurrent novel <i>MGA–NUTM1</i> fusion identifies a new subtype of high-grade spindle cell sarcoma mā Daniel Diolaiti, Filemon S. Dela Cruz, Gunes Gundem, Nancy Bouvier, Mathieu Boulad, Yanming Zhang, Alexander J. Chou, Ira J. Dunkel, Rashesh Sanghvi, Minita Shah, Heather Geiger, Sadia Rahman, Vanessa Felice, Kazimierz O. Wrzeszczyński, Robert B. Darnell, Cristina R. Antonescu, Christopher A. French, Elli Papaemmanuil, Andrew L. Kung, Neerav Shukla

I whakaputaina 2018

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
13

Impact of surgery, radiation and systemic therapy on the outcomes of patients with dendritic cell and histiocytic sarcomas mā Mrinal M. Gounder, Ved Desai, Deborah Kuk, Narasimhan P. Agaram, Maria E. Arcila, Benjamin H. Durham, Mary Louise Keohan, Mark A. Dickson, Sandra P. D’Angelo, Neerav Shukla, Craig H. Moskowitz, Ariela Noy, Robert G. Maki, Diego Adrianzen Herrera, Armando Sánchez, Anita Krishnan, Andrew Pourmoussa, Li-Xuan Qin, William D. Tap

I whakaputaina 2015

Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
14

Proteasome Addiction Defined in Ewing Sarcoma Is Effectively Targeted by a Novel Class of 19S Proteasome Inhibitors mā Neerav Shukla, Romel Somwar, Roger S. Smith, Sri Ambati, Stanley Munoz, Melinda S. Merchant, Pádraig D’Arcy, Xin Wang, Rachel Kobos, Christophe Antczak, Bhavneet Bhinder, David Shum, Constantin Radu, Guangbin Yang, Barry S. Taylor, Charlotte K.Y. Ng, Britta Weigelt, Inna Khodos, Elisa de Stanchina, Jorge S. Reis‐Filho, Ouathek Ouerfelli, Stig Linder, Hakim Djaballah, Marc Ladanyi

I whakaputaina 2016

Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
15

$Successful Targeted Therapy of Refractory Pediatric <i>ETV6-NTRK3</i> Fusion-Positive Secretory Breast Carcinoma$

Successful Targeted Therapy of Refractory Pediatric <i>ETV6-NTRK3</i> Fusion-Positive Secretory Breast Carcinoma mā Neerav Shukla, Stephen S. Roberts, Mollah Obayedullah Baki, Qazi Danish Mushtaq, Paul E. Goss, Ben Ho Park, Gunes Gundem, Ken Tian, Heather Geiger, Kristie Redfield, Gerald Behr, Ryma Benayed, Ahmet Zehir, Jaclyn F. Hechtman, Robert B. Darnell, Elli Papaemmanuil, Marc Ladanyi, Nora Ku, Andrew L. Kung, José Baselga, Alexander Drilon, David M. Hyman

I whakaputaina 2017

Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
16

Characterization of on-target adverse events caused by TRK inhibitor therapy mā D. Liu, James Flory, Andrew Lin, Michael Offin, Christina J. Falcon, Yonina R. Murciano‐Goroff, Ezra Rosen, Robin Guo, Ellen M. Basu, Bob T. Li, James J. Harding, Gopa Iyer, Komal Jhaveri, Mrinal M. Gounder, Neerav Shukla, Stephen S. Roberts, Julia Glade Bender, Lauren A. Kaplanis, Alison M. Schram, David M. Hyman, Alexander Drilon

I whakaputaina 2020

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
17

A recurrent neomorphic mutation in MYOD1 defines a clinically aggressive subset of embryonal rhabdomyosarcoma associated with PI3K-AKT pathway mutations mā Shinji Kohsaka, Neerav Shukla, Nabahet Ameur, Tatsuo Ito, Charlotte K.Y. Ng, Lu Wang, Diana Lim, Angela Marchetti, Agnès Viale, Mono Pirun, Nicholas D. Socci, Li-Xuan Qin, Raf Sciot, Julia A. Bridge, Samuel Singer, Paul A. Meyers, Leonard H. Wexler, Frederic G. Barr, Snjezana Doğan, Jonathan A. Fletcher, Jorge S. Reis‐Filho, Marc Ladanyi

I whakaputaina 2014

Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
18

Clonal hematopoiesis in survivors of childhood cancer mā Danielle Novetsky Friedman, Irenaeus C.C. Chan, Chaya S. Moskowitz, Shanita Li, Kimberly L. Turner, Jie Liu, Nancy Bouvier, Michael F. Walsh, Barbara Spitzer, Andrew L. Kung, Michael F. Berger, Megan A. Cooper, Iskra Pusic, Geoffrey L. Uy, Daniel C. Link, Todd E. Druley, Luis A. Díaz, Ross L. Levine, Neerav Shukla, Kelly L. Bolton

I whakaputaina 2023

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
19

The menin inhibitor revumenib in KMT2A-rearranged or NPM1-mutant leukaemia mā Ghayas C. Issa, Ibrahim Aldoss, John F. DiPersio, Branko Cuglievan, Richard M. Stone, Martha Arellano, Michael J. Thirman, Manish R. Patel, David S. Dickens, Shalini Shenoy, Neerav Shukla, Hagop M. Kantarjian, Scott A. Armstrong, Florian Perner, Jennifer A. Perry, Galit Rosen, Rebecca G. Bagley, Michael L. Meyers, Peter Ordentlich, Yu Gu, Vinit Kumar, Steven G. Smith, Gerard M. McGeehan, Eytan M. Stein

I whakaputaina 2023

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
20

Clonal evolution during metastatic spread in high-risk neuroblastoma mā Gunes Gundem, Max F. Levine, Stephen S. Roberts, Irene Y. Cheung, Juan S. Medina-Martínez, Yi Feng, Juan Arango Ossa, Loic Chadoutaud, Mathieu Rita, Georgios Asimomitis, Joe Zhou, Daoqi You, Nancy Bouvier, Barbara Spitzer, David B. Solit, Filemon S. Dela Cruz, Michael P. LaQuaglia, Brian H. Kushner, Shakeel Modak, Neerav Shukla, Christine A. Iacobuzio‐Donahue, Andrew L. Kung, Nai‐Kong V. Cheung, Elli Papaemmanuil

I whakaputaina 2023

Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i: